Sefa Tatar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sefa Tatar has a total of 62 co-authors. Here are the top co-authors by number of shared publications:
- Yakup Alsancak
Necmettin Erbakan University, Turkey
10 shared publications - Hakan Akilli
Department of Cardiology, Meram Faculty of Medicine, Necmettin Erbakan University, Konya, Turkey
7 shared publications - Yunus Emre Yavuz
Department of Cardiology, Meram Faculty of Medicine, Necmettin Erbakan University, Konya, Turkey.
7 shared publications Hakan Akilli
Necmettin Erbakan University
6 shared publications- Abdullah Icli
Department of Cardiology, Necmettin Erbakan University Medicine Faculty, Konya, Türkiye
5 shared publications - Ahmet Lütfü Sertdemir
Department of Cardiology, Medical Faculty, Necmettin Erbakan University
4 shared publications
Latest Publications
- Open Access
- 25 October 2026
- Published by Journal of Medicine and Palliative Care in Journal of Medicine and Palliative Care
- Vol. 7 (5) , 1138-1145
Echocardiographic diastolic indices and the ambulatory heart rate profile in preserved ejection fraction: implications for pre-exercise assessment
Aims: In patients with preserved ejection fraction, the relationship between routinely available echocardiographic indices and the ambulatory heart rate (HR) profile is not well defined. This study aimed to examine the association between echocardiographic diastolic and structural indices and the 24 h ambulatory (Holter) HR profile, with relevance to pre-exercise assessment.Methods: This single-center, retrospective study evaluated 300 adults with preserved left ventricular ejection fraction (LVEF ≥50%) who underwent both transthoracic echocardiography and 24 h Holter monitoring. The early-to-late diastolic mitral inflow velocity ratio (E/A), left atrial (LA) diameter, and pulmonary artery systolic pressure (PASP) were analyzed against the maximum, minimum, and mean HR and the HR range (maximum minus minimum), a descriptive index of daily HR behavior rather than a measure of exercise chronotropic reserve. Group comparison by E/A pattern, Spearman correlation, and multivariable linear regression were performed.Results: The HR range was higher in the E/A ≥1 group than in the E/A
- 25 October 2026
- Published by Journal of Medicine and Palliative Care in Journal of Medicine and Palliative Care
- Vol. 7 (5) , 1138-1145
Open AccessEchocardiographic diastolic indices and the ambulatory heart rate profile in preserved ejection fraction: implications for pre-exercise assessment
Aims: In patients with preserved ejection fraction, the relationship between routinely available echocardiographic indices and the ambulatory heart rate (HR) profile is not well defined. This study aimed to examine the association between echocardiographic diastolic and structural indices and the 24 h ambulatory (Holter) HR profile, with relevance to pre-exercise assessment.Methods: This single-center, retrospective study evaluated 300 adults with preserved left ventricular ejection fraction (LVEF ≥50%) who underwent both transthoracic echocardiography and 24 h Holter monitoring. The early-to-late diastolic mitral inflow velocity ratio (E/A), left atrial (LA) diameter, and pulmonary artery systolic pressure (PASP) were analyzed against the maximum, minimum, and mean HR and the HR range (maximum minus minimum), a descriptive index of daily HR behavior rather than a measure of exercise chronotropic reserve. Group comparison by E/A pattern, Spearman correlation, and multivariable linear regression were performed.Results: The HR range was higher in the E/A ≥1 group than in the E/A
- Open Access
- 22 June 2026
- Published by Springer Nature in Journal of Cardiovascular Translational Research
- Vol. 19 (1)
Left Ventricular Thrombus in Ischemic Heart Failure: Machine-learning–based Prediction of Six-month Persistence and One-year Outcomes
Left ventricular thrombus (LVT) in ischemic heart failure carries embolic risk; tools to anticipate persistence are limited. We studied 190 consecutive patients with imaging-confirmed LVT managed with guideline-concordant anticoagulation and serial echocardiography. The primary outcome was 6-month non-regression; 1-year MACE was secondary. We combined classical statistics with explainable machine learning. CatBoost yielded the best discrimination for non-regression (CV-AUC 0.76; test accuracy 0.79). SHAP highlighted left atrial diameter, pulmonary artery pressure, platelet count, and LV end-diastolic diameter as leading predictors. For 1-year outcomes, thrombus size and CHA2DS2-VA were independently associated with MACE (logistic AUC 0.71), whereas "regression vs persistence" alone was not. Baseline remodeling and coagulability markers, captured by an interpretable ML model, stratify early risk of LVT persistence and complement clinical decision-making for imaging follow-up and anticoagulation intensity.
- 22 June 2026
- Published by Springer Nature in Journal of Cardiovascular Translational Research
- Vol. 19 (1)
Open AccessLeft Ventricular Thrombus in Ischemic Heart Failure: Machine-learning–based Prediction of Six-month Persistence and One-year Outcomes
Left ventricular thrombus (LVT) in ischemic heart failure carries embolic risk; tools to anticipate persistence are limited. We studied 190 consecutive patients with imaging-confirmed LVT managed with guideline-concordant anticoagulation and serial echocardiography. The primary outcome was 6-month non-regression; 1-year MACE was secondary. We combined classical statistics with explainable machine learning. CatBoost yielded the best discrimination for non-regression (CV-AUC 0.76; test accuracy 0.79). SHAP highlighted left atrial diameter, pulmonary artery pressure, platelet count, and LV end-diastolic diameter as leading predictors. For 1-year outcomes, thrombus size and CHA2DS2-VA were independently associated with MACE (logistic AUC 0.71), whereas "regression vs persistence" alone was not. Baseline remodeling and coagulability markers, captured by an interpretable ML model, stratify early risk of LVT persistence and complement clinical decision-making for imaging follow-up and anticoagulation intensity.
- Open Access
- 18 May 2026
- Published by Kosuyolu Heart Journal, Health Sciences University in Kosuyolu Heart Journal
- Vol. 29 (2) , 153-156
Takotsubo Syndrome Presenting with Intrauterine Fetal Death in Late Pregnancy: A Diagnostic Challenge with Peripartum Cardiomyopathy
Peripartum cardiomyopathy (PPCM) is a major cause of heart failure in late pregnancy and the postpartum period, whereas takotsubo cardiomyopathy (TCM) is rare but may occur under severe stress. Differentiation between these conditions is challenging due to overlapping clinical features. A 30-year-old woman with an in vitro fertilization pregnancy presented at 34 weeks of gestation with dyspnea and intrauterine fetal demise. Echocardiography revealed severe left ventricular dysfunction (ejection fraction, 25%). Following surgical intervention and standard heart failure therapy, ventricular function improved rapidly, with the ejection fraction reaching 50% within one month. Despite pregnancy-related risk factors suggesting PPCM, the rapid recovery of left ventricular function favored a diagnosis of TCM. This case highlights the importance of careful clinical and imaging assessment and emphasizes that rapid ventricular recovery in late pregnancy should raise strong suspicion for TCM, even when classical PPCM risk factors coexist.
- 18 May 2026
- Published by Kosuyolu Heart Journal, Health Sciences University in Kosuyolu Heart Journal
- Vol. 29 (2) , 153-156
Open AccessTakotsubo Syndrome Presenting with Intrauterine Fetal Death in Late Pregnancy: A Diagnostic Challenge with Peripartum Cardiomyopathy
Peripartum cardiomyopathy (PPCM) is a major cause of heart failure in late pregnancy and the postpartum period, whereas takotsubo cardiomyopathy (TCM) is rare but may occur under severe stress. Differentiation between these conditions is challenging due to overlapping clinical features. A 30-year-old woman with an in vitro fertilization pregnancy presented at 34 weeks of gestation with dyspnea and intrauterine fetal demise. Echocardiography revealed severe left ventricular dysfunction (ejection fraction, 25%). Following surgical intervention and standard heart failure therapy, ventricular function improved rapidly, with the ejection fraction reaching 50% within one month. Despite pregnancy-related risk factors suggesting PPCM, the rapid recovery of left ventricular function favored a diagnosis of TCM. This case highlights the importance of careful clinical and imaging assessment and emphasizes that rapid ventricular recovery in late pregnancy should raise strong suspicion for TCM, even when classical PPCM risk factors coexist.
- Open Access
- 8 May 2026
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 26 (1)
TAPSE/PAi, a practical echocardiographic functional–structural index, better reflects functional severity than TAPSE/sPAP in pulmonary hypertension
We evaluated TAPSE/PAi, defined as the ratio of tricuspid annular plane systolic excursion to the indexed main pulmonary artery diameter, as a pragmatic functional-structural index and compared it with TAPSE/sPAP. In this retrospective study, 53 patients with PAH were analyzed. Associations of TAPSE/PAi and TAPSE/sPAP with clinical, biomarker, and invasive hemodynamic variables were assessed. Discrimination for WHO-FC ≥ 3, 6MWD < 165 m, and PVR > 5 WU was evaluated by direction-aligned ROC analysis with Youden-optimal thresholds. Age- and sex-adjusted logistic regression models reported odds ratios (ORs) per 1-SD increase. TAPSE/PAi correlated more strongly than TAPSE/sPAP with WHO-FC (ρ=-0.592 vs. -0.384) and 6MWD (ρ = 0.493 vs. 0.378), whereas TAPSE/sPAP correlated more strongly with NT-proBNP/proBNP (ρ=-0.619 vs. -0.484) and with mPAP/PVR. TAPSE/PAi showed better discrimination for WHO-FC ≥ 3 and 6MWD < 165 m while TAPSE/sPAP performed modestly better for PVR > 5 WU The Youden-optimal TAPSE/PAi threshold was ≤ 1.296 for both WHO-FC ≥ 3 and 6MWD < 165 m. The higher TAPSE/PAi remained associated with lower odds of WHO-FC ≥ 3 and 6MWD < 165 m after age- and sex-adjustment. TAPSE/PAi better reflects functional severity and exercise limitation, whereas TAPSE/sPAP is more closely related to biomarker/hemodynamic burden. The indices appear complementary, and TAPSE/PAi may be a practical TR-independent severity marker in PAH.
- 8 May 2026
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 26 (1)
Open AccessTAPSE/PAi, a practical echocardiographic functional–structural index, better reflects functional severity than TAPSE/sPAP in pulmonary hypertension
We evaluated TAPSE/PAi, defined as the ratio of tricuspid annular plane systolic excursion to the indexed main pulmonary artery diameter, as a pragmatic functional-structural index and compared it with TAPSE/sPAP. In this retrospective study, 53 patients with PAH were analyzed. Associations of TAPSE/PAi and TAPSE/sPAP with clinical, biomarker, and invasive hemodynamic variables were assessed. Discrimination for WHO-FC ≥ 3, 6MWD < 165 m, and PVR > 5 WU was evaluated by direction-aligned ROC analysis with Youden-optimal thresholds. Age- and sex-adjusted logistic regression models reported odds ratios (ORs) per 1-SD increase. TAPSE/PAi correlated more strongly than TAPSE/sPAP with WHO-FC (ρ=-0.592 vs. -0.384) and 6MWD (ρ = 0.493 vs. 0.378), whereas TAPSE/sPAP correlated more strongly with NT-proBNP/proBNP (ρ=-0.619 vs. -0.484) and with mPAP/PVR. TAPSE/PAi showed better discrimination for WHO-FC ≥ 3 and 6MWD < 165 m while TAPSE/sPAP performed modestly better for PVR > 5 WU The Youden-optimal TAPSE/PAi threshold was ≤ 1.296 for both WHO-FC ≥ 3 and 6MWD < 165 m. The higher TAPSE/PAi remained associated with lower odds of WHO-FC ≥ 3 and 6MWD < 165 m after age- and sex-adjustment. TAPSE/PAi better reflects functional severity and exercise limitation, whereas TAPSE/sPAP is more closely related to biomarker/hemodynamic burden. The indices appear complementary, and TAPSE/PAi may be a practical TR-independent severity marker in PAH.
- Open Access
- 22 April 2026
- Published by IMR Press in Reviews in Cardiovascular Medicine
- Vol. 27 (4)
A Comment on “Combination of the Fibrosis-4 Index and Carbohydrate Antigen 125 to Predict Morbidity and Mortality in Acute Heart Failure”
- 22 April 2026
- Published by IMR Press in Reviews in Cardiovascular Medicine
- Vol. 27 (4)
Open AccessA Comment on “Combination of the Fibrosis-4 Index and Carbohydrate Antigen 125 to Predict Morbidity and Mortality in Acute Heart Failure”
- 4 February 2026
- Published by SAGE Publications in JRSM Cardiovascular Disease
- Vol. 15
Is left ventricular relative wall thickness a predictor of 5-year mortality in patients with acute decompensated heart failure?
Objectives: Heart failure (HF) is a significant global health problem that continues to increase in prevalence, morbidity, and mortality, particularly in aging populations. Relative wall thickness (RWT), an echocardiographic parameter reflecting geometric remodeling of the heart, is easily measurable and may possess prognostic value. This study aimed to evaluate the predictive power of RWT for 5-year mortality in patients with HF. Methods: In this retrospective observational analysis, a total of 232 individuals diagnosed with acute decompensated heart failure were enrolled. RWT values were calculated using echocardiographic measurements. In this single retrospective cohort, participants were stratified into two subgroups based on their 5-year survival status. Demographic, clinical, laboratory, and echocardiographic parameters were compared between these subgroups Results: After 5 years of follow-up, 133 patients had died. Patients in the mortality group were significantly older (p = 0.001). The mortality cohort demonstrated a higher prevalence of chronic renal failure, atrial fibrillation, and mitral regurgitation compared with survivors. Echocardiographically, elevated systolic pulmonary artery pressure (sPAP) was associated with mortality (p = 0.009). However, regression analysis did not find sPAP to be statistically significant [95% confidence interval (CI), hazard ratio: 1.047 (0.818-1.340), p:0.7)]. RWT values did not show a significant difference between the groups (0.39 ± 0.13 compared to 0.37 ± 0.06; p = 0.225). Area under the curve for RWT was 0.50 (95% CI: 0.43–0.57), indicating poor predictive power. Kaplan–Meier analysis showed no significant difference in survival between RWT groups (log-Rank:0.984, p: 0.32). Conclusion: RWT has limited ability to predict 5-year mortality among patients with advanced stages of HF. Age emerged as the strongest independent predictor. RWT should be evaluated in conjunction with multiple clinical and laboratory parameters rather than in isolation when managing HF.
- 4 February 2026
- Published by SAGE Publications in JRSM Cardiovascular Disease
- Vol. 15
Is left ventricular relative wall thickness a predictor of 5-year mortality in patients with acute decompensated heart failure?
Objectives: Heart failure (HF) is a significant global health problem that continues to increase in prevalence, morbidity, and mortality, particularly in aging populations. Relative wall thickness (RWT), an echocardiographic parameter reflecting geometric remodeling of the heart, is easily measurable and may possess prognostic value. This study aimed to evaluate the predictive power of RWT for 5-year mortality in patients with HF. Methods: In this retrospective observational analysis, a total of 232 individuals diagnosed with acute decompensated heart failure were enrolled. RWT values were calculated using echocardiographic measurements. In this single retrospective cohort, participants were stratified into two subgroups based on their 5-year survival status. Demographic, clinical, laboratory, and echocardiographic parameters were compared between these subgroups Results: After 5 years of follow-up, 133 patients had died. Patients in the mortality group were significantly older (p = 0.001). The mortality cohort demonstrated a higher prevalence of chronic renal failure, atrial fibrillation, and mitral regurgitation compared with survivors. Echocardiographically, elevated systolic pulmonary artery pressure (sPAP) was associated with mortality (p = 0.009). However, regression analysis did not find sPAP to be statistically significant [95% confidence interval (CI), hazard ratio: 1.047 (0.818-1.340), p:0.7)]. RWT values did not show a significant difference between the groups (0.39 ± 0.13 compared to 0.37 ± 0.06; p = 0.225). Area under the curve for RWT was 0.50 (95% CI: 0.43–0.57), indicating poor predictive power. Kaplan–Meier analysis showed no significant difference in survival between RWT groups (log-Rank:0.984, p: 0.32). Conclusion: RWT has limited ability to predict 5-year mortality among patients with advanced stages of HF. Age emerged as the strongest independent predictor. RWT should be evaluated in conjunction with multiple clinical and laboratory parameters rather than in isolation when managing HF.
- 27 August 2025
- Published by Elsevier in Medicina Clinica
- Vol. 165 (6) , 107144
Effect of thrombolytic therapy in mortality of elderly patients with cancer and massive pulmonary embolism
- 27 August 2025
- Published by Elsevier in Medicina Clinica
- Vol. 165 (6) , 107144
Effect of thrombolytic therapy in mortality of elderly patients with cancer and massive pulmonary embolism
- Open Access
- 9 August 2025
- Published by Springer Nature in BMC Immunology
- Vol. 26 (1) , 60
Association of serum copeptin levels with pulmonary complications and heart right ventricular functions in common variable immunodeficiency
Common variable immunodeficiency (CVID) represents the most frequently diagnosed symptomatic primary immunodeficiency (PID), marked by a heterogeneous presentation involving infectious and non-infectious symptoms. This study investigated the association between serum copeptin levels and right ventricular functions (RVF) and pulmonary complications in patients diagnosed with CVID. The study analyzed data from 60 individuals with a confirmed diagnosis of CVID and 30 age- and sex-matched healthy volunteers (HVs). Clinical and biochemical parameters were sourced from existing hospital records.CVID patients were categorized into two subgroups: those with and without pulmonary complications. Comparisons of serum copeptin levels were made between these groups and between the overall CVID cohort and healthy controls. RVF was evaluated using tricuspid annular plane systolic excursion (TAPSE) and supplementary echocardiographic indicators. The CVID group had a median age of 40 years (interquartile range [IQR]: 30-55), with 51.7% being male, while the HVs group had a median age of 37 years (IQR: 28-47.5), with 60% male. No significant differences in age (p = 0.226) or sex distribution (p = 0.45) were observed between the groups. CVID with pulmonary complications (CVID-P) exhibited significantly elevated copeptin levels compared to those without such complications (p < 0.001). According to ROC analysis, a copeptin cut-off value of 11 pmol/L significantly differentiated patients with CVID-P from those without pulmonary complications (p < 0.001). Moreover, overall copeptin levels were significantly higher in the CVID group than in HVs (p < 0.001). A copeptin cut-off value of 21 pmol/L effectively distinguished CVID patients with low TAPSE from those with normal TAPSE values (p < 0.001). Pulmonary complications and low TAPSE were independently associated with increased copeptin levels (p = 0.006 and p = 0.004, respectively). The development of pulmonary complications and RV dysfunction were associated with elevated serum copeptin levels in CVID. Measuring serum copeptin concentration may be a useful biomarker in diagnosing and prognosis pulmonary diseases and RV dysfunction in CVID.
- 9 August 2025
- Published by Springer Nature in BMC Immunology
- Vol. 26 (1) , 60
Open AccessAssociation of serum copeptin levels with pulmonary complications and heart right ventricular functions in common variable immunodeficiency
Common variable immunodeficiency (CVID) represents the most frequently diagnosed symptomatic primary immunodeficiency (PID), marked by a heterogeneous presentation involving infectious and non-infectious symptoms. This study investigated the association between serum copeptin levels and right ventricular functions (RVF) and pulmonary complications in patients diagnosed with CVID. The study analyzed data from 60 individuals with a confirmed diagnosis of CVID and 30 age- and sex-matched healthy volunteers (HVs). Clinical and biochemical parameters were sourced from existing hospital records.CVID patients were categorized into two subgroups: those with and without pulmonary complications. Comparisons of serum copeptin levels were made between these groups and between the overall CVID cohort and healthy controls. RVF was evaluated using tricuspid annular plane systolic excursion (TAPSE) and supplementary echocardiographic indicators. The CVID group had a median age of 40 years (interquartile range [IQR]: 30-55), with 51.7% being male, while the HVs group had a median age of 37 years (IQR: 28-47.5), with 60% male. No significant differences in age (p = 0.226) or sex distribution (p = 0.45) were observed between the groups. CVID with pulmonary complications (CVID-P) exhibited significantly elevated copeptin levels compared to those without such complications (p < 0.001). According to ROC analysis, a copeptin cut-off value of 11 pmol/L significantly differentiated patients with CVID-P from those without pulmonary complications (p < 0.001). Moreover, overall copeptin levels were significantly higher in the CVID group than in HVs (p < 0.001). A copeptin cut-off value of 21 pmol/L effectively distinguished CVID patients with low TAPSE from those with normal TAPSE values (p < 0.001). Pulmonary complications and low TAPSE were independently associated with increased copeptin levels (p = 0.006 and p = 0.004, respectively). The development of pulmonary complications and RV dysfunction were associated with elevated serum copeptin levels in CVID. Measuring serum copeptin concentration may be a useful biomarker in diagnosing and prognosis pulmonary diseases and RV dysfunction in CVID.
- Open Access
- 30 June 2025
- Published by Cukurova Medical Journal in Cukurova Medical Journal
- Vol. 50 (2) , 370-379
Assessing the TAPSE/sPAP ratio for prognostic insight in HFpEF patients
Purpose: Heart failure with preserved ejection fraction (HFpEF) is closely associated with right heart dysfunction. Our study aimed to elucidate the association between HFpEF and the TAPSE/sPAP ratio. Materials and Methods: This retrospective observational study was conducted at a tertiary care cardiology clinic. A total of 64 patients diagnosed with HFpEF based on clinical criteria and an H2FPEF score ≥5 were included, along with 62 age- and sex-matched controls without heart failure symptoms. Demographic characteristics, laboratory markers, including NT-proBNP, and echocardiographic measurements were recorded. Particular attention was given to assessing right heart function using the TAPSE/sPAP ratio. Results: The TAPSE/sPAP ratio was lower in patients with HFpEF than in controls (median 0.76 vs. 0.96). Patients with HFpEF also had higher NT-proBNP levels (median 2136.5 pg/mL vs. 136.5 pg/mL) and higher H2FPEF scores. A TAPSE/sPAP cut-off value of 0.843 was identified, which showed 70.3% sensitivity and 72.6% specificity in distinguishing HFpEF. Correlation analysis revealed that lower TAPSE/sPAP ratios were associated with higher NT-proBNP levels, elevated H2FPEF scores, and increased left atrial volume index. Conclusion: The evaluation of the TAPSE/sPAP ratio in patients suspected of having HFpEF may be useful. Notably, TAPSE/sPAP predicted HFpEF regardless of EF in the multivariate analysis. In addition, their significant relationship with H2FPEF score and NT-proBNP levels strengthened their prognostic value.
- 30 June 2025
- Published by Cukurova Medical Journal in Cukurova Medical Journal
- Vol. 50 (2) , 370-379
Open AccessAssessing the TAPSE/sPAP ratio for prognostic insight in HFpEF patients
Purpose: Heart failure with preserved ejection fraction (HFpEF) is closely associated with right heart dysfunction. Our study aimed to elucidate the association between HFpEF and the TAPSE/sPAP ratio. Materials and Methods: This retrospective observational study was conducted at a tertiary care cardiology clinic. A total of 64 patients diagnosed with HFpEF based on clinical criteria and an H2FPEF score ≥5 were included, along with 62 age- and sex-matched controls without heart failure symptoms. Demographic characteristics, laboratory markers, including NT-proBNP, and echocardiographic measurements were recorded. Particular attention was given to assessing right heart function using the TAPSE/sPAP ratio. Results: The TAPSE/sPAP ratio was lower in patients with HFpEF than in controls (median 0.76 vs. 0.96). Patients with HFpEF also had higher NT-proBNP levels (median 2136.5 pg/mL vs. 136.5 pg/mL) and higher H2FPEF scores. A TAPSE/sPAP cut-off value of 0.843 was identified, which showed 70.3% sensitivity and 72.6% specificity in distinguishing HFpEF. Correlation analysis revealed that lower TAPSE/sPAP ratios were associated with higher NT-proBNP levels, elevated H2FPEF scores, and increased left atrial volume index. Conclusion: The evaluation of the TAPSE/sPAP ratio in patients suspected of having HFpEF may be useful. Notably, TAPSE/sPAP predicted HFpEF regardless of EF in the multivariate analysis. In addition, their significant relationship with H2FPEF score and NT-proBNP levels strengthened their prognostic value.
- 27 June 2025
- Published by Necmettin Erbakan University in Selcuk Tip Dergisi
Effect of Lupus Nephritis on Cardiac Remodeling and Left Ventricular Relative Wall Thickness
Amaç: Sistemik Lupus Eritematozus (SLE), yüksek kardiyovasküler komplikasyonlara yol açabilen otoimmün bir hastalıktır. Amacımız SLE'de böbrek tutulumunun sol ventrikül rölatif duvar kalınlığına (RWT) etkisini araştırmaktır. Gereçler ve Yöntem: Lupus nefriti olan ve olmayan SLE hastalarının ekokardiyografik özelliklerini karşılaştırmak için tek merkezli gözlemsel bir çalışma yapıldı. Çalışmaya toplam 125 hasta dahil edildi. Bulgular: Lupus nefriti olan hastaların ortalama yaşı 31, lupus nefriti olmayanlarda ise 40 idi. Lupus nefriti olan hastalarda interventriküler septum kalınlığının daha ince olduğu görüldü. Lupus nefritli hastalarda Mitral A dalgası daha düşüktü (62,5±17 vs. 74,9±20,5, p<0,05). Lupus nefritli hastalarda sol ventrikül RWT daha düşük olduğu hesaplandı (0,38±0,06 vs. 0,43±0,07, p<0,05). Sonuç: SLE yüksek kardiyovasküler komplikasyonlara yol açan ilerleyici bir hastalıktır. Lupus nefritinin gelişimi önemli miyokardiyal etkiye neden olur. Sol ventrikül RWT olumsuz kardiyovasküler sonuçları gösteren önemli bir parametredir. Anahtar Kelimeler: Sistemik Lupus Eritematozus, lupus nefriti, sol ventrikül, rölatif duvar kalınlığı, diyastolik fonksiyon bozukluğu
- 27 June 2025
- Published by Necmettin Erbakan University in Selcuk Tip Dergisi
Effect of Lupus Nephritis on Cardiac Remodeling and Left Ventricular Relative Wall Thickness
Amaç: Sistemik Lupus Eritematozus (SLE), yüksek kardiyovasküler komplikasyonlara yol açabilen otoimmün bir hastalıktır. Amacımız SLE'de böbrek tutulumunun sol ventrikül rölatif duvar kalınlığına (RWT) etkisini araştırmaktır. Gereçler ve Yöntem: Lupus nefriti olan ve olmayan SLE hastalarının ekokardiyografik özelliklerini karşılaştırmak için tek merkezli gözlemsel bir çalışma yapıldı. Çalışmaya toplam 125 hasta dahil edildi. Bulgular: Lupus nefriti olan hastaların ortalama yaşı 31, lupus nefriti olmayanlarda ise 40 idi. Lupus nefriti olan hastalarda interventriküler septum kalınlığının daha ince olduğu görüldü. Lupus nefritli hastalarda Mitral A dalgası daha düşüktü (62,5±17 vs. 74,9±20,5, p<0,05). Lupus nefritli hastalarda sol ventrikül RWT daha düşük olduğu hesaplandı (0,38±0,06 vs. 0,43±0,07, p<0,05). Sonuç: SLE yüksek kardiyovasküler komplikasyonlara yol açan ilerleyici bir hastalıktır. Lupus nefritinin gelişimi önemli miyokardiyal etkiye neden olur. Sol ventrikül RWT olumsuz kardiyovasküler sonuçları gösteren önemli bir parametredir. Anahtar Kelimeler: Sistemik Lupus Eritematozus, lupus nefriti, sol ventrikül, rölatif duvar kalınlığı, diyastolik fonksiyon bozukluğu